But will potential pharmaceutical tariffs nullify lower prescription costs? Plus Biden knocks DOGE Social Security job cuts.

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA) Medicare negotiation program, putting Medicare and beneficiary savings at risk.

The privatization of Medicare has been taking place without much public debate – a trend that KFF says has implications for the 68 million people covered by Medicare, health care providers, Medicare spending, and taxpayers.

In recent weeks, the Social Security Administration has been plagued by technology errors, staff cuts and even marking living people as dead, according to KFF Health News.

Social Security wait times to talk with a staffer by phone, email or in person have increased as the Trump administration, DOGE cut staffing, MSNBC reports.

A Biden administration policy capped the overpayment of Social Security clawbacks at 10%. Then the Trump administration came down hard with its overpayment demands on beneficiaries. Now there’s a quietly introduced change.

POLITICO reports Trump wanted the ‘most favored nation’ policy in his first term but faced resistance from the pharmaceutical industry and the courts.

More Americans are tapping benefits earlier than ever — but what’s driving this trend, and is it the right move?